Myasthenia gravis is a chronic autoimmune neuromuscular disorder characterized by weakness and rapid fatigue of voluntary muscles. It occurs when the immune system produces antibodies that block or destroy communication between nerves and muscles.
Market Overview and Key StatisticsThe Myasthenia Gravis Market size is expected to reach US$ 5.43 Billion by 2031. The market is anticipated to...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek